Retinoic acid inhibitors mitigate vision loss in a mouse model of retinal degeneration

Sci Adv. 2022 Mar 18;8(11):eabm4643. doi: 10.1126/sciadv.abm4643. Epub 2022 Mar 18.


Rod and cone photoreceptors degenerate in retinitis pigmentosa (RP). While downstream neurons survive, they undergo physiological changes, including accelerated spontaneous firing in retinal ganglion cells (RGCs). Retinoic acid (RA) is the molecular trigger of RGC hyperactivity, but whether this interferes with visual perception is unknown. Here, we show that inhibiting RA synthesis with disulfiram, a deterrent of human alcohol abuse, improves behavioral image detection in vision-impaired mice. In vivo Ca2+ imaging shows that disulfiram sharpens orientation tuning of visual cortical neurons and strengthens fidelity of responses to natural scenes. An RA receptor inhibitor also reduces RGC hyperactivity, sharpens cortical representations, and improves image detection. These findings suggest that photoreceptor degeneration is not the only cause of vision loss in RP. RA-induced corruption of retinal information processing also degrades vision, pointing to RA synthesis and signaling inhibitors as potential therapeutic tools for improving sight in RP and other retinal degenerative disorders.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Mice
  • Retinal Degeneration* / drug therapy
  • Retinal Degeneration* / etiology
  • Retinal Degeneration* / metabolism
  • Retinal Ganglion Cells / metabolism
  • Retinitis Pigmentosa* / drug therapy
  • Retinitis Pigmentosa* / metabolism
  • Tretinoin / metabolism
  • Tretinoin / pharmacology


  • Tretinoin